DETROIT Henry Ford Hospital is the first in the country to offer skin transplant surgery as part of its treatment portfolio for patients with the skin disease vitiligo.
The surgery, known as melanocyte-keratinocyte transplantation or MKTP, involves using skin cells taken from normally pigmented areas of the body and transferring them to the damaged area of skin to restore pigmentation. It is performed under local anesthesia as an outpatient procedure.
Patients who underwent the surgery as part of a 2010 research study at Henry Ford achieved striking results.
MKTP is a promising treatment option for vitiligo, which causes the skin to lose color and develop white patches that vary in size and location. It affects about one in every 200 people in the United States, and is more noticeable in people with darker skin. The late Michael Jackson and actor Jon Hamm of Mad Men are two notable celebrities to have vitiligo.
Henry Ford senior staff dermatologist Iltefat Hamzavi, M.D., says MKTP may be the most effective treatment to date for a segment of the more than 2 million patients living with vitiligo and the emotional side effects that accompany it.
"MKTP gives new hope to these patients," Dr. Hamzavi says. "First, it restores pigmentation to the skin; second, it gives patients' self-confidence a boost."
"You no longer have to be self-conscious about it," says Adil Siddiqui, 23, an electrical engineer and a resident of Canton who underwent MKTP for restoring pigment to patches around his lips. A topical cream initially prescribed had modest effectiveness.
MKTP is offered at Henry Ford's Vitiligo Treatment Center, which is part of the Multicultural Dermatology Clinic in the Department of Dermatology. Patients may call 313-916-1618 to make an appointment or visit http://www.henryford.com/vitiligo for more information.
Currently, the procedure is
|Contact: David Olejarz|
Henry Ford Health System